Tag: Vaccines
ACIP Recommends COVID-19 Vaccines for Children Aged ≥6 Months
ACIP interim recommendations presented for Moderna, Pfizer-BioNTech mRNA vaccines for children aged 6 months to 5 years
U.S. Begins Targeted Vaccine Rollout Against Monkeypox
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine
FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
Advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
More deaths would have been averted had vaccine coverage targets from COVAX and WHO been met
Fourth Dose of BNT162b2 Prevents Severe COVID-19 in Nursing Home Residents
Substantial protection against hospitalizations, deaths seen among long-term care facility residents during omicron surge
Pfizer Has Two Updated Booster Shots to Help Fight Omicron
Company said Saturday that it was confident its new booster candidates are better than their predecessor
FDA Panel to Weigh Improved Booster Shots From Moderna, Pfizer
Both Pfizer and Moderna have been testing updated booster shots that target the omicron variant
CDC Backs Moderna Vaccine for Those Aged 6 to 17
ACIP endorsed the shots after hearing the latest evidence on the vaccine's effectiveness
New York City Opens First Monkeypox Vaccine Clinic in U.S.
Announcement follows similar ones issued from the United Kingdom and Canada
COVID-19 Vaccine Does Not Increase CV Event Risk in Those With Existing Disease
Findings show safety of BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease
